CACNA1G and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy: This notion is supported by previous studies showing that CACNA1G (Cav3.1) and CACNA1A (Cav2.1) are genetic modifiers of epilepsy associated with Dravet syndrome [17–19].